Selected article for: "control arm and viral replication inhibit"
Author: Bird, Grace; Braithwaite, Irene; Harper, James; McKinstry, Steven; Koorevaar, Iris; Fingleton, James; Semprini, Alex; Dilcher, Meik; Jennings, Lance; Weatherall, Mark; Beasley, Richard
Title: Protocol for a randomised, single-blind, two-arm, parallel-group controlled trial of the efficacy of rhinothermy delivered by nasal high flow therapy in the treatment of the common cold
  • Document date: 2019_6_19
    • ID: x2xc1s14_40
    Snippet: In contrast to the recent feasibility study, 'sham' rhinothermy will be used as the control rather than Vitamin C. The use of 'Sham' rhinothermy in the control arm will provide the advantage of masking participants to treatment allocation and will control for any placebo effect associated with the use of a rhinothermy device. The rationale for the 'sham' device settings is to produce a treatment which is unlikely to have any therapeutic effect. F.....
    Document: In contrast to the recent feasibility study, 'sham' rhinothermy will be used as the control rather than Vitamin C. The use of 'Sham' rhinothermy in the control arm will provide the advantage of masking participants to treatment allocation and will control for any placebo effect associated with the use of a rhinothermy device. The rationale for the 'sham' device settings is to produce a treatment which is unlikely to have any therapeutic effect. For respiratory pathogens with temperature-dependent replication, a temperature of 31°C should not inhibit viral replication.

    Search related documents:
    Co phrase search for related documents
    • temperature dependent replication and therapeutic effect unlikely treatment: 1
    • temperature dependent replication and therapeutic effect unlikely treatment produce: 1
    • therapeutic effect and treatment allocation: 1
    • therapeutic effect and viral replication: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • therapeutic effect and viral replication inhibit: 1, 2, 3, 4
    • therapeutic effect and Vitamin control: 1
    • therapeutic effect unlikely treatment and treatment allocation: 1
    • therapeutic effect unlikely treatment and viral replication: 1
    • therapeutic effect unlikely treatment and viral replication inhibit: 1
    • therapeutic effect unlikely treatment and Vitamin control: 1
    • therapeutic effect unlikely treatment produce and treatment allocation: 1
    • therapeutic effect unlikely treatment produce and viral replication: 1
    • therapeutic effect unlikely treatment produce and viral replication inhibit: 1
    • therapeutic effect unlikely treatment produce and Vitamin control: 1
    • treatment allocation and viral replication: 1, 2
    • treatment allocation and viral replication inhibit: 1
    • treatment allocation and Vitamin control: 1
    • viral replication and Vitamin control: 1
    • viral replication inhibit and Vitamin control: 1